---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-036496"
form_type: "8-K"
ticker: "CELC"
cik: "0001603454"
company_name: "Celcuity Inc."
filed_at: "2022-12-23T23:59:59+00:00"
generated_at: "2026-06-20T23:21:03.147866+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Celcuity closes $20M term loan from Innovatus under existing credit facility

## Summary
- Closed $20.0M Term B Loan on Dec 22, 2022; part of previously disclosed $75M facility.
- Interest rate is greater of prime rate or 3.25% plus 5.70%; maturity April 8, 2027.
- Interest-only payments until May 1, 2025 (or May 1, 2026 if conditions met); 4.95% PIK elected.
- Innovatus can convert up to $6.6M of principal into common stock at $10.00 per share.
- Loan is secured by all assets; proceeds for working capital and general business needs.

## SEC filing metadata
- accession: 0001493152-22-036496
- form_type: 8-K
- ticker: CELC
- cik: 0001603454
- company_name: Celcuity Inc.
- filed_at: 2022-12-23T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1603454/000149315222036496/0001493152-22-036496-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1603454/000149315222036496/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-036496
- JSON: https://secwatch.observer/filing/0001493152-22-036496.json
- Plain text: https://secwatch.observer/filing/0001493152-22-036496.txt

## Key facts
- Debt Financings
  Celcuity Inc. incurred term loan of $20.0 million with Innovatus Life Sciences Lending Fund I, L.P. at at a rate equal to the sum of the greater of (i) the prime rate or (ii) 3.25%, p maturing April 8, 2027.
  - Instrument: term loan
  - Principal: $20.0 million
  - Counterparty: Innovatus Life Sciences Lending Fund I, L.P.
  - Rate: at a rate equal to the sum of the greater of (i) the prime rate or (ii) 3.25%, p
  - Maturity: April 8, 2027
  - Event: incurrence
  source text: On December 22, 2022, Celcuity Inc. (the “Company”) closed on a $20.0 million term loan (the “Term B Loan”) from Innovatus Life Sciences Lending Fund I, L.P., a Delaware limited partnership (“Innovatus”), pursuant to a Loan and Security Agreement, dated April 8, 2021 (the “Loan Agreement”), as amended by that First Amendment to Loan and Security Agreement, dated August 9, 2022 (the “Amendment and collectively with the Loan Agreement, the “Amended Loan Agreement”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1603454/000149315222036496/0001493152-22-036496-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.